comprehensive -WSS

comprehensive

author：fashion 2025-09-29 18:31:26 - browse：2378

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

explore

entertainment

WSS

Flagship, Pfizer team up in deal worth up to $7 billion

Biden administration sends mixed signals on US soldier who crossed into North Korea

Manchin plays down potential 3rd

US soldier in North Korean custody after crossing DMZ line

Abridge raises $150m as clinical notes automation market heats up

New CMS data security rules will hurt Medicare, Medicaid research

leisure time

comprehensive

hotspot

At least 13 dead in Texas as scorching temps continue

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

The high cost of giving birth even with insurance

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Apple is now the first public company to be valued at $3 trillion

Measles policy set amid Florida outbreak alarms vaccine proponents

The cancer drug shortage isn’t new — and neither are the solutions

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Malaria cases in Florida and Texas: Here’s what you need to know

New CMS data security rules will hurt Medicare, Medicaid research

leisure time

New study raises questions about niacin and heart health

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

A new drug could help frostbite victims avoid its ravages

Flagship Pioneering startup Sonata Therapeutics lays off 21

Hospitals are piloting generative AI tools as regulators play catch

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

explore

knowledge

entertainment

leisure time